ATM and breast cancer: If dysregulated gene expression causes BC development in carriers bearing ATM mutations and contributes to the A-T phenotype, it is possible that ER inhibitors that prevent BC development and gene therapy to correct dysregulated gene expression could relieve the severe symptoms of cerebellar degeneration.